Orion Portfolio Solutions’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.32M Sell
141,030
-38,867
-22% -$408K 0.01% 925
2024
Q4
$1.65M Buy
179,897
+12,383
+7% +$91K 0.02% 792
2024
Q3
$1.3M Sell
167,514
-5,155
-3% -$37.2K 0.01% 907
2024
Q2
$1.04M Buy
172,669
+62,432
+57% +$385K 0.01% 967
2024
Q1
$647K Buy
110,237
+20,835
+23% +$124K 0.01% 1169
2023
Q4
$570K Sell
89,402
-36,270
-29% -$252K 0.01% 1156
2023
Q3
$919K Buy
125,672
+50,639
+67% +$421K 0.01% 961
2023
Q2
$783K Buy
75,033
+760
+1% +$7.32K 0.01% 1046
2023
Q1
$768K Buy
+74,273
New +$951K 0.01% 986
2020
Q3
Sell
-148
Closed -$2K 517
2020
Q2
$2K Buy
+148
New +$1.52K ﹤0.01% 1731

Other funds holding ANGO

Orion Portfolio Solutions's ANGO Position: Q1 2025 in Review

Orion Portfolio Solutions reduced its AngioDynamics (ANGO) stake by 22% in Q1 2025, selling an estimated $408K and leaving 141,030 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #925.

Orion Portfolio Solutions first reported a position in ANGO in Q2 2020 and has held it in 10 quarters since. The position peaked at $1.65M in Q4 2024. 154 funds tracked by Wall St. Rank hold ANGO as of Q1 2025.

  • Orion Portfolio Solutions held 141,030 shares of AngioDynamics worth $1.32M as of Q1 2025.
  • Orion Portfolio Solutions sold 38,867 AngioDynamics shares in Q1 2025, an estimated $408K.
  • AngioDynamics made up 0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #925 holding.
  • Orion Portfolio Solutions first reported a position in AngioDynamics in Q2 2020 and has held it in 10 quarters since.
  • Orion Portfolio Solutions's AngioDynamics position peaked at $1.65M in Q4 2024.
  • 154 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.